![]() |
市場調查報告書
商品編碼
1348454
靜脈注射套組的全球市場:規模,佔有率,趨勢分析(2024年~2030年):MedCoreIntravenous Set Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore | Includes: Pump Sets, Secondary Sets, and 2 more |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2023年,全球靜脈注射器市場規模預計將呈現穩定成長,總估值達60億美元,較上年的57億美元大幅成長5.1%。該市場在預測期內繼續以 4.1% 的複合年增長率成長,預計最終將達到 79 億美元。全球靜脈注射器市場的現況很大程度取決於兩大參與者的存在:碧迪公司(BD)和貝朗公司。
隨著外科和創傷領域的不斷發展,靜脈注射器的需求顯著增加。無論是在繁忙的醫院手術室還是在繁忙的門診環境中,輸液治療都作為準確管理和施用輸液和藥物的生命線發揮著至關重要的作用。此外,在緊急醫療情況、危重治療情況和創傷病例中,快速可靠地進入靜脈對於復甦和穩定目的至關重要。正是在這些緊張的時刻,在持續血管通路的基本需求的推動下,對靜脈輸液器的需求急劇上升。
2023年,Becton Dickinson (BD) 成為全球靜脈注射器市場的領導者。BD多年來在輸液治療及相關治療市場各個方面的強勢地位,為其推動這一領先地位發揮了至關重要的作用。BD的獨特優勢在於其能夠將靜脈輸液器與多種配套產品捆綁在一起,這項策略為公司帶來了顯著的效益。這項策略使 BD 能夠以競爭對手無法匹敵的每套價格提供大量 IV 套裝。
本報告提供全球靜脈注射套組市場相關調查,提供市場概要,以及各市場區隔,各地區趨勢,競爭情形等資訊。
In 2023, the worldwide market for intravenous (IV) sets exhibited robust growth, with a total valuation of $6.0 billion, marking a substantial 5.1% increase from the previous year when it stood at $5.7 billion. Projections indicate continued growth momentum throughout the forecast period, with a compound annual growth rate (CAGR) of 4.1%, ultimately reaching an estimated value of $7.9 billion. Notably, the current landscape of the global intravenous set market is predominantly influenced by the presence of two major players, namely Becton Dickinson (BD) and B. Braun.
Our extensive medical market research efforts encompassed a comprehensive evaluation of more than 25 intravenous set companies spanning across all seven continents. Employing a rigorous methodology, we delved into various facets of the market, including market sizes, unit sales, company market shares, and generated precise forecasts. The complete report suite dedicated to the global market for intravenous sets encompasses a range of categories, including pump sets, secondary sets, gravity sets, and extension sets.
Within the ever-evolving realm of surgical procedures and trauma cases, there is a notable upswing in the demand for intravenous (IV) sets. Whether within the bustling confines of hospital operating rooms or in more mobile ambulatory settings, IV therapy assumes a pivotal role as a lifeline for the controlled administration of fluids and medications with precision. Moreover, in instances of emergent medical scenarios, critical care situations, and traumatic injuries, the immediate and dependable access to veins becomes paramount for the purpose of resuscitation and stabilization. It is within these intense and time-sensitive moments that the requirement for IV sets experiences a significant surge, driven by the indispensable need for consistent vascular access.
In the year 2023, Becton Dickinson (BD) emerged as the foremost leader in the global IV set market. BD's entrenched position in various other facets of infusion therapy and related treatment markets over the years played a pivotal role in elevating it to this top-tier status. BD's distinctive advantage lies in its ability to bundle IV sets with a range of complementary products, a strategy that bestows significant benefits upon the company. This approach occasionally empowers BD to offer IV sets in substantial quantities and at a per-set cost that smaller competitors find challenging to match.
Claiming the second position in the global IV set market for 2023 was B. Braun. The company exhibited a robust presence in the pump set market, driven by its dominant role in the realm of large-volume infusion pumps. B. Braun held a significant market share in IV sets, particularly in key Western European markets such as Germany and Italy. Beyond Western Europe, the company maintained noteworthy, albeit somewhat smaller, shares in other regions.
The remaining segment of the IV set market remained fragmented, featuring a diverse array of competitors. The relatively modest manufacturing costs associated with IV sets make this sector an attractive space for smaller players to enter. Furthermore, the majority of companies engaged in the production and distribution of infusion pumps also complement their capital products with infusion sets, thereby contributing to the diversity of offerings within the market.